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Abstract Congenital anomalies of the kidney and urinary
tract, as well as primary vesico-ureteric reflux (VUR) and
associated renal dysplasia, are the most relevant causes of
end-stage renal failure in the pediatric population. In vivo
and in vitro experimental studies have allowed the
identification of several genes involved both in ureteric
bud branching, ureteric elongation and insertion into the
bladder, and in nephrogenesis. It has been proposed that
both renal and ureteral abnormalities, as well as the
associated renal hypo-dysplasia, may derive from a com-
mon mechanism as the result of a dysregulation of the
normal developmental program. The large homologies
between mice and the human genome suggest that the
same genes could be involved both in rodent and human
VUR. Furthermore, epidemiological observations suggest
that not only syndromic but also isolated VUR is an
inherited trait. Linkage analysis for homologous mouse
genes in humans, genome-wide linkage studies in multi-
generational families and association studies by polymor-
phisms support the hypothesis that VUR is genetically
heterogeneous and is caused by a number of different genes
acting with random environmental effects. The present
teaching paper is an overview of the embryology and
genetics of primary VUR and associated congenital reflux
nephropathy.
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Introduction
Primary vesico-ureteric reflux (VUR) is a congenital defect
of the urinary tract that causes urine to flow retrogradely
from the bladder to the kidneys and it is not associated with
any underlying neuromuscular or obstructive phenomenon
[1]. Galen and Leonardo Da Vinci firstly described the
oblique entry of ureter into the bladder that prevents the
back-up of urine during bladder voiding. Later animal
studies and human observations showed that developmental
defects of the vesico-ureteric junction determining VUR
include inadequate length of the intravesical ureter; the
defective muscle layer of the trigone that encompasses the
ureter adjoining the bladder and ectopic ureteral orifices
within the trigone. VUR is a risk factor for upper urinary
tract infections (UTI), causing pyelonephritis and renal
scarring. Recurrent scarring and subsequent chronic renal
damage may lead to progressive renal failure. VUR
prevalence in the pediatric population is 1%. NAPRTCS
and European registries report that 8% of patients affected
by VUR develop end-stage renal failure as a result of
“reflux nephropathy”, which accounts for 25% of end-stage
renal disease [1–3]. Probably, many other individuals with
VUR hidden in the population are affected by renal
dysplasia and/or hypoplasia, which represent the major
cause of end-stage renal failure. However, the prevention of
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UTI by clinical management (antibiotic prophylaxis) and/or
by surgical correction of VUR have not significantly reduced
the incidence of renal failure in these patients. Non-
functioning renal units associated with VUR and end-stage
renal failure are mostly hypo-dysplastic kidneys. The
histological picture of dysplastic kidneys is characterized by
the presence of renal parenchymal areas with various degrees
of differentiation together with areas of undifferentiated
nephrogenic mesenchyme and cartilaginous metaplasia, with
or without different localized and extended tubular, ductal or
glomerular cysts (Fig. 1). It is still controversial whether
renal dysplasia is due to poor nephrogenic differentiation
resulting from the back pressure effect of urine reflux on the
developing fetal kidney. The degree of renal dysplasia does
not correlate well with the severity of reflux. More recently,
it has been proposed that both renal and ureteral abnormal-
ities may derive from a common mechanism as the result of
a dysregulation of the normal developmental program
occurring very early during embryogenesis. Nephrouroge-
netic programming requires a complex sequential and
temporal regulation of genes in terms of activation and
repression. Experimental gene knock-out models have
enabled the identification of some genes associated with
VUR and reflux nephropathy, and mutations of murine-
homologous human genes are responsible for syndromic
forms of VUR-associated hypo-dysplasia.
Embryology of the kidney and urinary tract:
the developmental theory of vesico-ureteric reflux
In humans, as in other mammalian species, the kidney and
ureter derive from a mesodermic tissue, the metanephros,
which develops in close proximity to the mesonephric
Wolffian duct, which extends to fuse with the cloaca, the
urinary bladder precursor, and drains the transitory kidneys
(pro- and mesonephroi; Fig. 2). The metanephros consists
of two components: the ureteric bud and the metanephric
mesenchyme. The former gives rise to the collecting ducts,
the renal pelvis, the ureter, and the bladder trigone, while
the latter differentiates into tubules (from distal tubules up
to the glomerulus) and renal stroma. The development of
both the components depends on a series of reciprocal
inductive signals: at the end of the 4th week of gestation,
metanephric mesenchyme induces the nearby Wolffian duct
to evaginate an epithelial tube, the ureteric bud. This
invades the metanephric mesenchyme, which in response
condenses, proliferates, and undergoes an epithelial trans-
formation at approximately the 5th week of gestation. In
turn, the distal end of the ureteric bud branches to form the
collecting system in response to contact with the stimulated
metanephric mesenchyme. The proximal end of the ureteric
bud remains attached to the mesonephric duct and
elongates, becoming the distal ureter. The common nephric
duct, the segment of the mesonephric duct that lies between
the ureter and urogenital sinus or primitive bladder, under-
goes programmed cell death. This permits the ureter to
begin its incorporation into the bladder, during which it
acquires a tunnel and a muscle layer that connects to the
trigone [2].
In children with ureteral malformations, Mackie and
Stephens observed two kinds of morphologic correlation:
between the location of the ureteral orifice and the
abnormalities of the ureter (i.e., VUR); and between the
location of the ureteral orifice and the degree of kidney dys-
or hypoplasia (cited in [4]).
In the developing embryo, the ureteral orifice travels
from its original budding site on the Wolffian duct to the
final destination into the bladder as the Wolffian duct
region is absorbed into the developing bladder. The final
site of the ureteral orifice depends on the position where the
ureteric bud exits from the mesonephric duct, which in turn
depends on the time and location of the contact with the
metanephric mesenchyme. For example, if the ureteric bud
develops at a site too caudal along the Wolffian duct, its
final location within the bladder will be abnormally cranial
to the normal site (Fig. 3). This aberrancy results in the
poor development of a “short” ureterovesical valve and
VUR. Concurrently, the normal interaction between the
ureteric bud and the metanephric blastema required for
normal renal parenchyma growth and differentiation is also
Fig. 1 Vesico-ureteric reflux-associated renal dysplasia. Dysplastic
kidneys are characterized by the presence of renal parenchymal areas
with various degrees of differentiation together with areas of
undifferentiated nephrogenic mesenchyme and cartilaginous metapla-
sia, with or without different localized and extended tubular, ductal or
glomerular cysts (Masson’s Trichromic dye, ×40)
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disrupted. The ureteral budding from an aberrant site
contacts the metanephric mesenchyme at a point where
mesenchymal cells are scarce, resulting in formation of
hypoplastic and dysplastic kidneys. Renal hypo-dysplasia is
not the result of urine reflux, but both kidney and ureter
malformation derive from an aberrant contact between the
ureteric bud and the metanephric blastema [4]. In the last
decade, in vitro (organ culture) and in vivo (knock-out
animal) studies and gene expression profile analysis on
developing kidneys have provided essential data for the
generation of hypotheses regarding the molecular control of
nephrogenesis, enabling the identification of hundreds of
implicated molecules, including growth/survival factors,
cell adhesion molecules, and transcription factors.
Molecular regulation of nephrogenesis and candidate
genes of VUR
Primum movens for metanephros development is the
formation of the metanephrogenic mesenchyme [5]. This
event depends on the prior activation in the intermediate
mesoderm of transcription factors produced by normally
formed pronephros and mesonephros, such as Lim-1, Pax-
2, Eya-1, and Foxc-1 (Fig. 4) [6]. Once it has formed, the
mesenchyme secretes Gdnf (glial-derived neurotrophic
factor), inducing the nearby Wolffian duct to give out the
ureteric bud, which invades the metanephric blastema and
begins its branching and elongation. In lim-1−/− mice, the
intermediate mesenchyme is disorganized and fails to
express other proteins necessary for kidney development
such as Pax-2. This is a transcription factor expressed in
mesonephros and later in metanephros. Pax-2−/− mice fail
to form any kidney [7]. In knock-out mice for the
transcriptional co-activator Eya-1, the caudal end of the
intermediate mesenchyme never produces Gdnf and so
never initiates metanephric development. Foxc-1−/− mice
show a disorganization of mesonephroi and their meta-
nephrogenic mesenchyme forms too anteriorly, causing the
ureter to be positioned further forward than usual, or an
additional ureter to form on the same side. More recently, it
has been reported that mesenchymal expression of Sall1
transcription factor is necessary for early inductive events
in murine kidney [6]. When metanephric mesenchyme is
formed, the primary signal that it emanates is the growth
factor Gdnf, which stimulates the ureteric bud out-growing
from the Wolffian duct through its receptor c-Ret (retinoic
acid receptor), a tyrosine kinase, and its Gfr-1α coreceptor,
both expressed by the ureteric bud. This signaling system
continues to operate after bud induction, sustaining its intra-
Fig. 2 Schematic represen-
tation of early events in kidney
development (modified from
[30])
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mesenchymal arborization. The importance of the Gdnf/Ret
pathway has been confirmed by the absence of kidneys in
homozygous null mutant mice and by the absence of
ureteric out-growth in experiments with blocking antibodies
to Gdnf in culture of whole metanephric rudiments.
Conversely, the addition of Gdnf to cultured metanephroi
induces ectopic ureters. The receptor tyrosine kinase
antagonist Spry1 negatively regulates the Gdnf/Ret-signal-
ing pathway, such that in Spry1−/− mice the mesonephric
duct is more sensitive to Gdnf and develops multiple
ureteric buds [5, 6, 8]. In the HoxB7/Ret transgenic mouse
Ret is over-expressed and the kidneys are small and cystic
with grossly dilated ureters and a shorter intravesical
tunnel, into which urine flows retrogradely from the
Fig. 4 Overview of genes in-
volved in ureteric bud induction.
MM metanephric mesenchyme,
UB ureteric bud, WD wolffian
duct. See text for details (mod-
ified from [8])
Fig. 3 Dynamics of the kidney
and ureteral development
according to the “bud theory”.
Relationship between ureteric
bud position on the Wolffian
duct to the nephrogenic blaste-
ma and orifice positions in the
bladder and urethra. A Ectopic
bud orifice on the lateral and
cranial end of the extended
hemitrigone (site a), resulting in
VUR. B Normal ureteric bud
orifice B on the corner (site b).
C Ectopic bud orifice on the
caudal extremity of the bladder.
The metanephric mesenchyme is
well differentiated when inter-
acting with a bud at the normal
site B but sparse and poorly
differentiated around bud A and
C (from [4])
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bladder, resulting in postnatal VUR. Mice lacking either
Ret, or an enzyme required for retinoic acid synthesis have
malformed kidneys and defects in the distal ureter: in
males, the ureter remains attached to the mesonephric duct,
which forms the deferent duct in adults, while it inserts into
the uterus in females. Signaling through vitamin A and
Gdnf/Ret is required for the common nephric duct to
contact the urogenital sinus and undergo apoptosis during
the formation of the vesico-ureteric junction.
Expression of Ret by the ureteric bud requires other
transcription factors such as Emx-2; bud development also
depends on the mesenchyme-derived growth factor Hgf
with its tyrosine kinase receptor c-Met. Members of the
bone morphogenetic protein family exert varied effects on
ureteric bud development: Bmp-2 acts as a powerful
inhibitor of ureteric bud branching, restricting ramification
to the terminal part of the bud; Bmp-4 expression in the
stroma around the ureteric bud and along the stalk of the
ureteric bud prevents the ureteric bud from forming too
early, or anteriorly along the Wolffian duct and bifurcating
before it invades the mesenchyme. Heterozygous bmp-4+/−
mice are animal models of vesico-ureteric junction abnor-
malities, which are often associated with bifid ureters.
Many other growth factors, such as Tgf-β and Fgf, and
some components of the extracellular matrix, such as
glycosaminoglycans and proteins, partly secreted by the
bud and partly by the surrounding mesenchyme, have been
found to participate in ureteric development.
Recently, 20 different transcripts have been identified as
potentially important in metanephros development by micro-
array analyses on the rat tips of the ureteric tree. One of these is
the cytokine-like factor 1 (Cfl-1), which induces mature
nephron structures expressing glomerular and tubular markers
when applied to isolated rat metanephric mesenchyme. The
isolation of metanephrogenic mesenchyma from the ureteric
bud would result in its death, but this fate is reversed by
factors secreted by the bud, such as Tgf-α, Timp-2, Egf, and
Fgf-2. Other factors, such as Lif and Tgf-β2, cooperate with
the previously induced clumps of mesenchyme cells to
differentiate into nephrons, while Bmp-7 appears to lead
them instead to form stroma [9]. As nephrons form, they
express transcription factors such as Pax-2 and Hoxa-11, and
condense and secrete Wnt-4, which acts in an autocrine loop
to stimulate its own synthesis and is required for mesenchy-
mal cells to differentiate into epithelia. As well as acquiring
their basic epithelial character, nephron cells have to
differentiate to produce specialized functional regions. Main-
tained expression of Pax-2 is necessary for nephron tubule
elongation, but its inhibition by Wt-1 is fundamental for
normal glomerular development. While Pax-2 homozygous
null mutant mice develop renal hypo-dysplasia associated
with various urinary tract malformations such as VUR, Pax-2
over-expression induces hyper-proliferative tubular cysts and
a failure of mature glomerular development [10]. Many other
proteins have been recognized to be involved in region
differentiation of the nephron, such as Lmx-1b, Notch-2,
Jagged-1, and Hnf-1, but a larger number of molecules with
similar activities are still to be identified [3]. Figure 5
summarizes candidate genes for VUR and urinary tract
malformations, and their genomic loci in mice.
Briefly, experimental models suggest that:
1. Developmental anomalies of the urinary tract are due to
alterations perturbing the complex gene network that
controls nephrourogenesis
2. The different phenotypes of renal and ureteric malfor-
mations may depend on the stage of nephrogenesis at
which the alteration of the developmental program
occurs: renal agenesis should be the result of the
complete lack of metanephric induction by the ureteric
bud; different degrees of dysplasia associated with
urinary tract anomalies, such as VUR, should originate
from the disruption of the normal ureteral branching
and elongation, and the epithelial differentiation
processes
3. A mutation affecting a single gene may result in
different phenotypes, and mutations of different genes
can result in the same disease
4. Dysregulation of an upstream gene of a metabolic
pathway may alter the function of one or more
downstream genes of that very metabolic pathway or
of other related ones, involved in the determination of a
specific phenotype (modifier gene)
It has also been shown that not only a lack of transcription
of a gene, but also its overexpression, may be responsible
for a disease.
Genetic basis of VUR
On the basis of human homolog gene knock-out mice
models, which have identified a series of genes responsible
for the normal or abnormal development of the urinary
tract, a genetic basis for VUR and the associated renal
dysplasia may be hypothesized in humans. VUR can occur
as part of complex syndromes with an inherited pattern
[11]. The genetic hypothesis is also supported by epidemi-
ological evidence: isolated VUR has a high incidence in the
population with ethnic differences between affected and
non-affected individuals (reduced incidence in African
Americans); monozygotic twins show 80–100% concor-
dance for VUR compared with 35–50% concordance in
dizygotic twins; 30–50% of the siblings of affected children
have VUR and familial clustering of isolated VUR is well
described.
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In humans, as in mice, renal tract disorders occur with
multiorgan malformation syndromes commonly affecting
eyes and the central nervous, cardiovascular, and skeletal
systems. Although individually rare, malformation syn-
dromes collectively account for significant morbidity. Some
are associated with gross chromosomal anomalies such as
monosomy of chromosome X, trisomy of chromosomes 13,
18, and 21; deletion of chromosomes 4p, 5p, and 11p; and
several microdeletions such as chromosome 7q, 22q11, and
17p11.2. However, cytogenetic rearrangements are absent
in most children born with syndromic urinary tract
malformations. Table 1 summarizes human syndromes with
VUR with their own inheritance pattern. Several syndromes
have an identified gene (mice homolog), whose protein and
function are also well known.
Mendelian inherited syndromes with renal hypo/
dysplasia and VUR
Renal-coloboma syndrome (RCS; OMIM 120330) is an
autosomal dominant disorder characterized by optic nerve
coloboma and renal anomalies, which commonly include
renal hypoplasia and VUR. Auditory, CNS, and skin/joint
anomalies may also be present. Renal and/or ocular
manifestations are found in all patients, although a marked
phenotypic variability has been observed. Sanyanusin first
described heterozygous mutations of the PAX2 gene in
patients with renal-coloboma syndrome [12]. An experi-
mental model revealed that Pax-2−/− mutant mice lack
kidneys and a ureter because the ureteric bud fails to branch
from the mesonephric duct, while haplo-insufficiency (a
lack of functional protein due to a mutated allele) in Pax-2
+/− mutant mice is associated with renal hypoplasia and
sometimes hydro-ureteronephrosis consistent with the pres-
ence of vesico-ureteric reflux [13]. Human PAX2 gene maps
to chromosome 10q24–25 and comprises 12 exons. The
first four exons encode a highly conserved DNA-binding
domain, essential for transcription factor function, whose
role during kidney and ureter development has been
discussed above. To date, many different PAX2 mutations
have been reported in humans, most frequently affecting
exon 2 (http://www.hgu.mrc.ac.uk/Softdata/PAX2). Pheno-
typic variability has been observed not only with differing
mutations, but also with the same mutation and within the
same family, and PAX2 mutations have also been reported
in isolated renal hypoplasia and in VUR [14].
Branchio-oto-renal syndrome (BOR; OMIM 113650)
segregates as an autosomal dominant disease with incom-
plete penetrance and variable expressivity. Common phe-
notypic features comprise deafness, preauricular pits/tags,
branchial and external ear malformations, and renal
anomalies including renal hypo/dysplasia with abnor-
malities of the collecting system and VUR. In 1997,
Abdelhak identified mutations in a novel gene called
EYA1 in seven affected patients [15]. In further reports, 51
different mutations of EYA1 (http://www.medicine.uiowa.
edu/pendredandbor) have been associated with BOR syn-
drome, including point mutations and complex rearrange-
ments, which may involve every exon and seem to be
randomly scattered throughout the gene. There is no single
common mutation, but most mutations are unique to indi-
vidual families. EYA1 maps on chromosome 8q13.3 and is
the human homolog of the Drosophila “eyes absent” gene,
which is involved in the development of all components of
the inner ear. In the developing kidney, the gene is required
for metanephric development, as reported above.
EYA1 mutations are detected in approximately 40% of
patients with clinical diagnosis of BOR syndrome. An
additional gene, SIX1 (Drosophila sine oculis homologue),
which interacts with EYA1 and PAX2 in a complex network
of genes that control the development of kidneys, ears, and
other organs, has been identified [16].
Townes-Brocks syndrome (TBS; OMIM 107480) is an
autosomal dominantly inherited disorder, which comprises
multiple defects, including imperforate anus, preaxial
polydactyly, and/or triphalangeal thumbs and dysplastic
ears. Further manifestations include renal anomalies such as
hypo/dysplastic kidney and urinary tract malformations,
foot malformations, congenital heart defects, and, rarely,
mental retardation. Among urinary tract malformations
reported in TBS, VUR has also been described [17].
Significant intra- and inter-familiar phenotypic variability
has been noted and clinical features overlapping with BOR
Fig. 5 Candidate genes for vesico-ureteric reflux and urinary tract malformations and their genomic loci in mice (modified from [3])
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syndrome have been reported. TBS has been shown to
result from mutation in the SALL1 (Drosophila sall
homologue) gene, which maps on chromosome 16q12.1
and encodes a zinc finger protein thought to act as a
transcriptional repressor (see above). The gene comprises
three exons, containing four highly conserved double zinc
finger domains. To date, 35 different mutations have been
reported, mostly frameshift mutations occurring in exon 2
and found 5′ to or within the region encoding the first
double zinc finger. SALL1 mutation analysis in TBS has
failed as yet to demonstrate a clear genotype–phenotype
correlation. One hypothesis is that SALL1 mutations cause
TBS via haplo-insufficiency, as most of the observed
mutations insert premature termination codons [18]. How-
ever, Sall1 heterozygous knock-out mice showed normal
phenotype, while homozygous mutants had isolated kidney
defects without other TBS manifestations. In other animal
models, heterozygotes already showed a TBS-like pheno-
Table 1 Human syndromes with vesico-ureteric reflux (VUR)











VUR, HN, ureteral atresia/stenosis Aminoaciduria, MR, muscular
dystrophy, visual abnormality
XL





Branchio-oto-renal VUR, renal agenesis, hypoplasia/
dysplasia, duplicity, obstruction, HN
Branchial remnant, preauricular pit/
tag, microtia, deafness
AD EYA1 or SIX1
Cat eye VUR, renal agenesis, hypo/dysplasia,
duplicity, HN








VUR, renal hypoplasia, duplicity, HN Conotruncal CHD, thymic aplasia,























VUR, renal hypoplasia, renal aplasia Hypoparathyroidism, deafness AD GATA3
Kabuki VUR, horseshoe kidney, duplicity, HN, MR, Kabuki-like face, large ears,
cleft palate
U












VUR, HN, ureteral/urethra diverticulae Postaxial polydactyly of hands and
feet
U
Renal-coloboma VUR, renal hypoplasia/dysplasia, renal
agenesis
Optic nerve coloboma, nerve
deafness
AD PAX2
Urogenital adysplasia VUR, renal agenesis, renal hypo/
dysplasia, HN





VUR, horseshoes kidney, renal
hypoplasia
Absent uterus, broad forehead, DD,
large fontanel
AR
Townes-Brocks VUR, renal agenesis, renal dysplasia,
duplicity, ureteral/urethra diverticulae
Triphalangeal thumb, imperforate
anus, skin tag, deafness
AD SALL1
Wolfram VUR, HN Diabetes mellitus/insipidus, optic
atrophy, nerve deafness
M WFS1-2
AD autosomal dominant, AR autosomal recessive, C chromosomal, CHD congenital heart disease, DD development delay, HN hydro-
ureteronephrosis, M mitochondrial, MR mental retardation, S sporadic, SS short stature, U uncertain, XL X-linked (modified from [2]).
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type and TBS was considered to be caused by mutations
leading to truncated protein with a dominant negative
effect.
In hypoparathyroidism-sensorineural deafness and renal
disease syndrome (HDR; OMIM 146255), urinary mani-
festations include renal aplasia or hypoplasia, pelvicaliceal
deformity, and VUR. The type and severity of clinical
manifestations may range over a wide phenotypic spectrum.
The syndrome has an autosomal dominant pattern of
inheritance, even though an autosomal recessive mode of
inheritance has also been hypothesized. Hasegawa first
described HDR syndrome in a girl with a de novo 10p
deletion [19]. Subsequent molecular deletion analysis
defined a critical region for the disease on 10p14–15. In
this context, a zinc finger transcription factor, GATA3, has
been mapped. Human GATA3 expression has been detected
in the developing parathyroid glands, inner ears, kidney,
thymus, and CNS. Gata3 null mutant mice show renal
hypoplasia and developmental defects in structures derived
from cephalic neural crest cells. Heterozygous human
GATA3 abnormalities predicting a loss of function, namely
one nonsense mutation, two intragenic deletions, and two
whole gene deletions, have been identified in several
families with HDR syndrome, suggesting that the haplo-
insufficiency of GATA3 is the major cause of the disease
[20].
Primary isolated VUR: candidate gene identification
by family studies
The increased sibling recurrence rates as well as parent–
offspring transmission strongly implicate hereditary factors
in the development of primary isolated VUR. The severity
of VUR varies between affected individuals in a family and
abnormalities often improve or can entirely resolve with
age, making complete ascertainment of affected family
members difficult. Moreover, asymptomatic individuals are
rarely screened, as the diagnosis often requires invasive
procedures. Finally, establishing the diagnosis of reflux
nephropathy is equally problematic.
Nonetheless, familial clustering of isolated primary VUR
and/or reflux nephropathy have been described and a broad
range of inheritance patterns have been reported from
family studies, including autosomal-dominant with incom-
plete penetrance, autosomal-recessive, sex-linked, and even
multifactorial. Only Chapman et al.’s study used complex
segregation analysis to determine the most likely genetic
model. In that set of families, a single dominant gene was
best able to explain the transmission of the trait [21].
More recently, multigenerational families with both
VUR and reflux nephropathy were examined by genome-
wide linkage analysis by Feather et al. In 5 of the 7 families
analyzed, VUR mapped to a locus on chromosome 1p13
[22]. In the other two families, no linkage was shown to
this region, implicating additional genomic loci in VUR,
and 12 additional loci were identified genome-wide with p
>0.05. No significant linkage was found to 6p, an HLA
locus hypothesized to increase the susceptibility to infection
and progression to reflux nephropathy, or to PAX2.
A candidate approach to test the association of primary
VUR with already reported loci (1p13, 3p12, 6p21, 10q26,
and 19q13) did not yield any significant LOD scores [23].
Other authors identified a 13q deletion in several
children affected by VUR and reported congenital anoma-
lies of kidney and urinary tract (CAKUT)-associated locus
on 13q12–22. These authors very recently described the
results of cyto- and molecular genetic studies to identify a
second region on chromosome 13 that is located on 13q33–
34 and is associated with CAKUT such as severe VUR and
reflux nephropathy [24]. The critical region spans approx-
imately 7 Mb and includes 33 genes; in murine models,
several of these genes show mRNA expression patterns that
suggest their potential involvement in renal/urinary tract
development anomalies.
Literature data support the hypothesis that VUR is
genetically heterogeneous and is caused by different genes
acting either alone or in combination, along with random
environmental effects.
Is VUR a multifactorial complex disorder?
Multifactorial disorders result from complex interactions
between a number of predisposing factors including the
genotype and a variety of environmental exposures that
trigger, accelerate, or exacerbate the disease process. In
contrast to mendelian single-gene defects, there is only a
handful of multifactorial diseases whose underlying genetic
model is known. The major approach used to locate and
identify genes that predispose to complex disease is
association study, which compares the frequencies of
particular alleles between affected and unaffected individ-
uals, enabling the identification of high- and low-risk
persons with a predisposition to complex disorders. This
genetic analysis is performed using different polymor-
phisms (DNA variations) that are present at least in 1–2%
of normal individuals. In humans, association studies in the
VUR-affected population have been performed by poly-
morphisms of the genes involved in kidney and urinary
tract development previously identified in animal models
[25].
The renin angiotensin system (RAS) appears to play an
important role in renal development [26]. Angiotensinogen
mutant mice have atrophic papillae with pelvic space
enlargement, chronic interstitial inflammation and fibrosis,
as well as ACE (angiotensin converting enzyme) and
angiotensin II type 1 receptor (AGTR1) null mutant mice.
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Conversely, angiotensin II type 2 receptor (AGTR2) null
mutant mice have urological disorders, including both
obstructive anomalies and reflux, with or without renal
hypo/dysplasia. On the basis of these experimental studies,
several authors have hypothesized that genetic polymor-
phisms of the RAS components may be important factors in
VUR-including CAKUT development and progression.
However, the results of these studies are conflicting:
polymorphisms in ACE and AGTR2 have been inconsis-
tently associated with VUR, reflux nephropathy or com-
bined kidney and urinary tract anomalies.
An analogous result has been demonstrated for Uropla-
kin genes. Uroplakins (UP) are a group of four membrane
proteins that are synthesized by mammalian urothelium, the
lining of most of the lower urinary tract, including the
proximal urethra, bladder, ureter, and renal pelvis. Genetic
ablation of UPIII causes VUR in mice [27]. In humans,
UPIIIa heterozygous mutations cause renal adysplasia and
severe VUR was described in two unrelated kindreds, one
isolated and the other associated with a persistent cloaca
[28]. In a population of 76 VUR patients, 18 single
nucleotide polymorphisms (SNPs), seven of them missense,
were found in all four UP genes, but only a weak
association between the two UP polymorphisms and VUR
was observed [29]. This suggests that missense changes of
UP genes cannot play a dominant role in causing VUR in
humans, although they may be weak risk factors contrib-
uting to complex polygenic disease.
Conclusions
Animal and human studies suggest that VUR and the
associated renal dysplasia may result from a dysregulation
of the complex gene network that regulates the normal
developmental program of the kidneys and urinary tract.
Molecular and genetic studies have greatly increased our
understanding of VUR, but the human gene(s) responsible
for primary VUR remain to be found. Future approaches to
gene mapping technology will allow a better understanding
of the genetic factors that underlie VUR.
Study Questions (Answers appear following the reference list)
Directions: Each of the numbered items is followed by
several possible answers. Select the ONE lettered answer
that is BEST in each case.
1. What percentage of chronic renal failure in pediatric




2. In which structures are Gdnf and Ret expressed during
kidney development?
a) Both in metanephric mesenchyme
b) In metanephric mesenchyme and in the ureteric bud
respectively
c) In the ureteric bud and in the cloaca
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